Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of BH009 vs Winthrop Docetaxel in Solid Tumors
NCT04889599Phase 3Completed
- Sponsor
- Zhuhai Beihai Biotech
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Albumin, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beizray in solid tumor, sponsored by Zhuhai Beihai Biotech. Started Apr 2021; status: completed.
02
Drugs
beizray
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04889599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04889599.